HPLC Purity vs. Mass Balance: What a COA Number Actually Means

A Certificate of Analysis (COA) is the single most important document accompanying any research peptide, and the HPLC purity figure at the top of the page is the number most frequently cited when comparing suppliers. It is also the number most frequently misread. A 99% HPLC purity result does not mean the vial contains 99% peptide by mass — the two are related but distinct measurements, and understanding the difference is a prerequisite for interpretable bench work.

HPLC purity, typically reported as area-percent at a specified detection wavelength (commonly 214 nm for peptide-bond absorbance), is a measure of how much of the UV-absorbing material eluting from the column is the target peptide relative to related-substance impurities. It is a chromatographic quality metric describing the peptide fraction of the sample, not a mass-balance quantitation of the vial contents.

The remainder of the vial mass, which HPLC purity does not describe, consists of water (residual moisture from the lyophilization process), counterions (typically acetate or trifluoroacetate from the final purification step), and any excipients. For a well-lyophilized peptide, residual moisture is commonly in the 3–8% range, and counterion content depending on peptide charge state and purification chemistry can add another 5–15%. A COA reporting 99% HPLC purity together with a peptide content of 82% is not contradictory — the peptide fraction of the material in the vial is 82%, and 99% of that peptide fraction is the intended sequence.

For quantitative in-vitro work, peptide content matters more than HPLC purity. Dose-response curves and receptor-binding Kd/Ki determinations require accurate knowledge of the moles of active peptide in the assay well. A COA that reports HPLC purity alone, without peptide content by nitrogen analysis or amino-acid analysis and without counterion identity and content, is incomplete for quantitative pharmacology.

Identity confirmation by mass spectrometry is the third essential COA element. The observed monoisotopic or average mass should match the theoretical mass of the intended sequence within the instrument tolerance stated on the report — typically a few Daltons for a MALDI instrument or sub-Dalton for a high-resolution LC-MS. Any deviation greater than instrument tolerance is a red flag for a sequence error, a modification (oxidation, deamidation), or a mislabeled vial.

A rigorous COA therefore reports at minimum: HPLC purity with method conditions, mass by MS with theoretical and observed values, counterion identity and content, and either peptide content or a documented assumption about it. Batch-specific COAs from independent third-party laboratories such as Janoshik Analytical carry these elements as a matter of course, and laboratories relying on peptide reference material should require nothing less.

All materials described are for in-vitro laboratory research only and are not for human or veterinary use.